Kamada Ltd
NASDAQ:KMDA
| Market Cap (Intraday) | 445.65M |
| Current PE | 27.75 |
| Forward PE | 23.48 |
| 2yr Forward PE | 19.87 |
| 10-Day MA | $7.76 |
| 50-Day MA | $7.12 |
| 200-Day MA | $6.43 |
Kamada Ltd Stock, NASDAQ:KMDA
Science Park, 2 Holzman Street, Rehovot, HaMerkaz 7670402
Israel
Phone: +972.8.940.6472
Number of Employees: 420
Description
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.